vs
Arbutus Biopharma Corp（ABUS）与AVINO SILVER & GOLD MINES LTD（ASM）财务数据对比。点击上方公司名可切换其他公司
AVINO SILVER & GOLD MINES LTD的季度营收约是Arbutus Biopharma Corp的2.0倍（$21.0M vs $10.7M），AVINO SILVER & GOLD MINES LTD净利率更高（36.6% vs 23.5%，领先13.1%），Arbutus Biopharma Corp同比增速更快（522.2% vs 44.0%），过去两年AVINO SILVER & GOLD MINES LTD的营收复合增速更高（51.1% vs -13.2%）
Arbutus生物制药是一家公开上市的加拿大生物制药企业，专长于脂质体药物递送与RNA干扰技术，目前主要开展针对乙型肝炎感染的治疗药物研发工作，在抗病毒新药研发领域拥有深厚的技术积累。
阿维诺金银矿业有限公司是一家加拿大矿业企业，主要从事银、金、铜等贵金属及基本金属的勘探、开发与生产，核心运营资产为位于墨西哥杜兰戈州的旗舰阿维诺矿区，产品供应全球大宗商品市场。
ABUS vs ASM — 直观对比
营收规模更大
ASM
是对方的2.0倍
$10.7M
营收增速更快
ABUS
高出478.2%
44.0%
净利率更高
ASM
高出13.1%
23.5%
两年增速更快
ASM
近两年复合增速
-13.2%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.7M | $21.0M |
| 净利润 | $2.5M | $7.7M |
| 毛利率 | — | 47.1% |
| 营业利润率 | 13.9% | — |
| 净利率 | 23.5% | 36.6% |
| 营收同比 | 522.2% | 44.0% |
| 净利润同比 | 112.7% | 558.9% |
| 每股收益（稀释后） | $0.01 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABUSASM
| Q3 25 | — | $21.0M | ||
| Q2 25 | $10.7M | $21.8M | ||
| Q1 25 | — | $18.8M | ||
| Q3 24 | — | $14.6M | ||
| Q2 24 | — | $14.8M | ||
| Q1 24 | — | $12.4M | ||
| Q4 23 | $2.1M | — | ||
| Q3 23 | $4.7M | $12.3M |
净利润ABUSASM
| Q3 25 | — | $7.7M | ||
| Q2 25 | $2.5M | $2.9M | ||
| Q1 25 | — | $5.6M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $599.0K | ||
| Q4 23 | — | — | ||
| Q3 23 | $-20.1M | $-803.0K |
毛利率ABUSASM
| Q3 25 | — | 47.1% | ||
| Q2 25 | — | 46.9% | ||
| Q1 25 | — | 56.1% | ||
| Q3 24 | — | 39.1% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 18.9% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 19.2% |
营业利润率ABUSASM
| Q3 25 | — | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -967.2% | — | ||
| Q3 23 | -462.8% | — |
净利率ABUSASM
| Q3 25 | — | 36.6% | ||
| Q2 25 | 23.5% | 13.1% | ||
| Q1 25 | — | 29.8% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 4.8% | ||
| Q4 23 | — | — | ||
| Q3 23 | -431.6% | -6.5% |
每股收益（稀释后）ABUSASM
| Q3 25 | — | $0.05 | ||
| Q2 25 | $0.01 | $0.02 | ||
| Q1 25 | — | $0.04 | ||
| Q3 24 | — | $0.01 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $0.00 | ||
| Q4 23 | $-0.12 | — | ||
| Q3 23 | $-0.12 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | $57.3M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $83.0M | $182.1M |
| 总资产 | $103.3M | $221.9M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ABUSASM
| Q3 25 | — | $57.3M | ||
| Q2 25 | $37.4M | $37.3M | ||
| Q1 25 | — | $26.6M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $3.5M | ||
| Q4 23 | $126.0M | — | ||
| Q3 23 | $17.5M | $1.9M |
总债务ABUSASM
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — |
股东权益ABUSASM
| Q3 25 | — | $182.1M | ||
| Q2 25 | $83.0M | $144.8M | ||
| Q1 25 | — | $132.3M | ||
| Q3 24 | — | $114.5M | ||
| Q2 24 | — | $112.2M | ||
| Q1 24 | — | $107.8M | ||
| Q4 23 | $106.0M | — | ||
| Q3 23 | $119.3M | $102.7M |
总资产ABUSASM
| Q3 25 | — | $221.9M | ||
| Q2 25 | $103.3M | $174.7M | ||
| Q1 25 | — | $157.7M | ||
| Q3 24 | — | $135.4M | ||
| Q2 24 | — | $133.7M | ||
| Q1 24 | — | $128.6M | ||
| Q4 23 | $144.4M | — | ||
| Q3 23 | $158.6M | $123.5M |
负债/权益比ABUSASM
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.00× | — | ||
| Q3 23 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.7M | $8.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -6.24× | 1.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABUSASM
| Q3 25 | — | $8.3M | ||
| Q2 25 | $-15.7M | $8.3M | ||
| Q1 25 | — | $758.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $2.3M | ||
| Q4 23 | $-17.3M | — | ||
| Q3 23 | $-21.8M | $-83.0K |
自由现金流ABUSASM
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-21.8M | — |
自由现金流率ABUSASM
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -468.4% | — |
资本支出强度ABUSASM
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.7% | — |
现金转化率ABUSASM
| Q3 25 | — | 1.08× | ||
| Q2 25 | -6.24× | 2.92× | ||
| Q1 25 | — | 0.13× | ||
| Q3 24 | — | 3.55× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 3.92× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
